CN101199607A - Nose kang tea - Google Patents
Nose kang tea Download PDFInfo
- Publication number
- CN101199607A CN101199607A CNA200710009991XA CN200710009991A CN101199607A CN 101199607 A CN101199607 A CN 101199607A CN A200710009991X A CNA200710009991X A CN A200710009991XA CN 200710009991 A CN200710009991 A CN 200710009991A CN 101199607 A CN101199607 A CN 101199607A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- tea
- radix
- kang
- rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001122767 Theaceae Species 0.000 title claims description 15
- 239000003814 drug Substances 0.000 claims abstract description 22
- 241000628997 Flos Species 0.000 claims description 20
- 241000255791 Bombyx Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 206010039083 rhinitis Diseases 0.000 abstract description 19
- 235000013616 tea Nutrition 0.000 abstract description 12
- 229940079593 drug Drugs 0.000 abstract description 7
- 235000015091 medicinal tea Nutrition 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 2
- 229940126701 oral medication Drugs 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 2
- 241000906579 Actaea cimicifuga Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000218394 Magnolia liliiflora Species 0.000 abstract 1
- 240000004370 Pastinaca sativa Species 0.000 abstract 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002688 persistence Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000001331 nose Anatomy 0.000 description 6
- 206010039085 Rhinitis allergic Diseases 0.000 description 4
- 201000010105 allergic rhinitis Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010039088 Rhinitis atrophic Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001969 hypertrophic effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000158526 Nasalis Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a therapeutic preparation containing reaction products originated from plant materials, in particular to a Bikang tea medicinal tea for curing rhinitis. The invention adopts the technical proposal that: the medicament is prepared by following ingredients by weight ratios: 1-3g of magnolia liliflora, 1-3g of ligusticum sinense, 2-5g of Astragalus root, 1-3g of broadleaf holly leaf, 1-3g of notopterygium incisium, 1-2g of cimicifuga foetida, 1-3g of hemlock parsley, 1-2g of dahurian angelica, 1-3g of parsnip, 1-3g of silkworm larva, 0.5-1.5g of asarum, 1-3g of herba schizonepetae and 1-3g of chrysanthemum. The medicinal tea is prepared by using the modern Chinese traditional medicine making process, a cup of tea can be taken before going to bed every night with safety and convenience, outstanding curative effect and easy persistence, and the invention can effectively solve the defects that the pathogenic QI in the body repels the property of a drug when taking the oral drug, and the drug can not be absorbed and is ejected from the stomach immediately, so the invention deserves promotion and application.
Description
Technical field
The present invention relates to contain the medicinal preparation that derives from the vegetable material product, especially belong to a kind of nose kang tea medicinal tea for the treatment of rhinitis.
Background technology
Rhinitis refers to the inflammation of nasal membrane and submucous tissue, and its performance is varied.From pathological change, allergic rhinitis, sinusitis, chronic simple rhinitis, chronic hypertrophic rhinitis, atrophic rhinitis etc. are arranged; From the slow length that reaches the course of disease of the urgency of morbidity, can be divided into acute rhinitis and chronic rhinitis.In addition, some rhinitis are arranged, though morbidity is slowly, the course of disease continues longer, and specific pathogenesis is arranged, just thereby specific title is arranged, as allergic rhinitis (that is allergic rhinitis), medicamentous rhinitis etc.At present, though the method for treatment rhinitis inflammation is a lot, curative effect still can not be satisfactory.
Summary of the invention
The object of the present invention is to provide a kind of easy, economical, have no side effect and treat rhinitis nose kang tea medicinal tea evident in efficacy.
The technical solution used in the present invention is: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 1-3g Rhizoma Ligustici 1-3g Radix Astragali 2-5g Folium Ilicis 1-3g Rhizoma Et Radix Notopterygii 1-3g
Rhizoma Cimicifugae 1-2g Rhizoma Chuanxiong 1-3g Radix Angelicae Dahuricae 1-2g Radix Saposhnikoviae 1-3g Bombyx Batryticatus 1-3g
Herba Asari 0.5-1.5g Herba Schizonepetae 1-3g Flos Chrysanthemi 1-3g.
Beneficial effect of the present invention is: the present invention is based on the theory of " integration of edible and medicinal herbs, the doctor supports in like manner ", with dredge the meridian passage, lung qi dispersing is sensible, expelling wind and cold, and sensible expelling pathogenic factors from the exterior, nourshing Yin and drynsessmoistening prescription, heat-clearing and toxic substances removing is the Therapeutic Principle.Through clinical application in many ways, develop the nose kang tea medicinal tea of treatment rhinitis, the pure Chinese crude drug of its selected the Nature, modern Chinese medicine processing technology with routine is made medicinal tea, potion is made tea just before going to bed every night, safe ready, evident in efficacy, be easy to adhere to, and can effectively solve the oral medication pathogenic QI in the body and property of medicine phase cell is refused, medicine is gone into stomach and is promptly told and can not receive the drawback of medicine, is worth of widely use.
Theory of Chinese medical science is inquired into: the traditional Chinese medical science thinks that rhinitis is that lung meridian is hot and suffocating owing to attacked by wind and cold, wind heat repeatedly, and clear respectful not normal, air flue is unclear, the failure of nose key, and the body fluid heap soil or fertilizer over and around the roots stagnates, and with the passing of time turns to turbid tears, grows stream and forms this disease as the deep pool.In addition, the heresy of wind and cold, wind heat is directly encroached on Naohu, causes that brain is not solid, is primary disease and ooze under the turbid tears.But be to become because of wind and cold condensates into Naohu with the damp and hot friendship steaming of the sun always, lung meridian is hot and suffocating and brain gas is solid all can cause rhinitis.And the clinical symptoms of rhinitis morbidity is different, very harmful, when influencing the physiological function of nasal cavity, respiratory disorder can appear, cause blood oxygen concentration and reduce, influence the function and the metabolism of other tissue and organ, and some occur as headache, dizzy, hypomnesis, chest pain, uncomfortable in chest, listlessness etc., in addition can concurrent emphysema, severe complications such as pulmonary heart disease, asthma.Medicine of the present invention is made up of pure Chinese crude drugs such as Flos Magnoliae, Rhizoma Ligustici, the Radix Astragali, Folium Ilicis, Rhizoma Et Radix Notopterygii, Rhizoma Cimicifugae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Radix Saposhnikoviae, Bombyx Batryticatus, Herba Asari, Herba Schizonepetae, Flos Chrysanthemis.Brew with boiling water and drink as long as get a bag medicated tea before sleeping every night during use.Full side's combined effect dredging the meridian, QI and blood regulating, sensible, the sensible expelling pathogenic factors from the exterior of lung qi dispersing, strengthening healthy qi, adjustment internal organs negative and positive tend to balance the state of body imbalance, reach the purpose of disease preventing and treating.
The specific embodiment
Concrete formulation Example of the present invention is as follows:
Embodiment 1: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 1g Rhizoma Ligustici 1g Radix Astragali 2g Folium Ilicis 1g Rhizoma Et Radix Notopterygii 1g
Rhizoma Cimicifugae 1g Rhizoma Chuanxiong 1g Radix Angelicae Dahuricae 1g Radix Saposhnikoviae 1g Bombyx Batryticatus 1g
Herba Asari 0.5g Herba Schizonepetae 1g Flos Chrysanthemi 1g.
Embodiment 2: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 3g Rhizoma Ligustici 3g Radix Astragali 5g Folium Ilicis 3g Rhizoma Et Radix Notopterygii 3g
Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 3g Radix Angelicae Dahuricae 2g Radix Saposhnikoviae 3g Bombyx Batryticatus 3g
Herba Asari 1.5g Herba Schizonepetae 3g Flos Chrysanthemi 3g.
Embodiment 3: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 2g Rhizoma Ligustici 2g Radix Astragali 4g Folium Ilicis 2g Rhizoma Et Radix Notopterygii 2g
Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 2g Radix Angelicae Dahuricae 2g Radix Saposhnikoviae 2g Bombyx Batryticatus 2g
Herba Asari 1g Herba Schizonepetae 2g Flos Chrysanthemi 2g.
The present invention is made up of pure Chinese crude drugs such as Flos Magnoliae, Rhizoma Ligustici, the Radix Astragali, Folium Ilicis, Rhizoma Et Radix Notopterygii, Rhizoma Cimicifugae, Rhizoma Chuanxiong, the Radix Angelicae Dahuricae, Radix Saposhnikoviae, Bombyx Batryticatus, Herba Asari, Herba Schizonepetae, Flos Chrysanthemis, adopt conventional modern Chinese medicine processing technology, through cut into slices, pulverize, mix homogeneously, the tea bag inner packing of packing into becomes medicated tea.
Brew with boiling water and drink as long as get a bag medicated tea before sleeping every night when the present invention uses.
Therapeutic outcome of the present invention:
According in " the disease of tcm diagnosis criterion of therapeutical effect " of State Administration of Traditional Chinese Medicine promulgation about the efficacy assessment standard of rhinitis:
Recovery from illness: sniffle disappears, and the nasal cavity inspection is normal, nasal cavity cleaning, and BITONG gas is good, and the X line is taken the photograph sheet and is shown that the hole chamber is clear, does not have recurrence more than 3 months;
Produce effects: sniffle disappears substantially, and BITONG gas is good, and the glutinous on a small quantity tears of nasal cavity, X line are taken the photograph apparent slightly the increasing of sheet demonstration hole chamber density;
Effectively: sniffle alleviates, and the pus tears obviously reduce, sxs such as mucosa hyperemia, concha nasalis enlargement;
Invalid: symptom and sign do not have to change to wait and judge efficacy result.
And with reference to " eye, hals,Nasen und Ohrenheilkunde medical diagnosis on disease standard ", all case is all made diagnosis according to medical history, the inspection of nostril, front and back, nasal sinuses X-ray film or CT scan.
Below all medical records all from prosperous subhealth state institute of week, case is collected and to be lasted one-year age.76 routine rhinitis patients, male 45 examples, women 31 examples; The oldest person 46 years old, age reckling 13 years old.Chronic simple rhinitis 32 examples wherein, allergic rhinitis 11 examples, chronic hypertrophic rhinitis 10 examples, sinusitis 14 examples, atrophic rhinitis's 7 examples.
Use " nose kang tea " after three months, cure 59 examples among the 76 routine patients, account for 77.6%; Produce effects 8 examples account for 10.5%; Effective 4 examples account for 5.3%; Invalid 5 examples account for 6.6%.Treated back 3 months～1 year, and followed up a case by regular visits to 47 patients, still do not have 1 example recurrence.
Claims (4)
1. nose kang tea is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 1-3g Rhizoma Ligustici 1-3g Radix Astragali 2-5g Folium Ilicis 1-3g Rhizoma Et Radix Notopterygii 1-3g
Rhizoma Cimicifugae 1-2g Rhizoma Chuanxiong 1-3g Radix Angelicae Dahuricae 1-2g Radix Saposhnikoviae 1-3g Bombyx Batryticatus 1-3g
Herba Asari 0.5-1.5g Herba Schizonepetae 1-3g Flos Chrysanthemi 1-3g.
2. according to the described nose kang tea of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 1g Rhizoma Ligustici 1g Radix Astragali 2g Folium Ilicis 1g Rhizoma Et Radix Notopterygii 1g
Rhizoma Cimicifugae 1g Rhizoma Chuanxiong 1g Radix Angelicae Dahuricae 1g Radix Saposhnikoviae 1g Bombyx Batryticatus 1g
Herba Asari 0.5g Herba Schizonepetae 1g Flos Chrysanthemi 1g.
3. according to the described nose kang tea of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 3g Rhizoma Ligustici 3g Radix Astragali 5g Folium Ilicis 3g Rhizoma Et Radix Notopterygii 3g
Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 3g Radix Angelicae Dahuricae 2g Radix Saposhnikoviae 3g Bombyx Batryticatus 3g
Herba Asari 1.5g Herba Schizonepetae 3g Flos Chrysanthemi 3g.
4. according to the described nose kang tea of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Flos Magnoliae 2g Rhizoma Ligustici 2g Radix Astragali 4g Folium Ilicis 2g Rhizoma Et Radix Notopterygii 2g
Rhizoma Cimicifugae 2g Rhizoma Chuanxiong 2g Radix Angelicae Dahuricae 2g Radix Saposhnikoviae 2g Bombyx Batryticatus 2g
Herba Asari 1g Herba Schizonepetae 2g Flos Chrysanthemi 2g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710009991XA CN101199607B (en) | 2007-12-11 | 2007-12-11 | Bikang tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710009991XA CN101199607B (en) | 2007-12-11 | 2007-12-11 | Bikang tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199607A true CN101199607A (en) | 2008-06-18 |
| CN101199607B CN101199607B (en) | 2012-04-18 |
Family
ID=39515088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710009991XA Expired - Fee Related CN101199607B (en) | 2007-12-11 | 2007-12-11 | Bikang tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199607B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815167A (en) * | 2015-05-15 | 2015-08-05 | 王健军 | Traditional Chinese medicine preparation for treating rhinitis |
| CN105168749A (en) * | 2015-09-24 | 2015-12-23 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine composite for treating wind-cold affecting lung syndrome type secretory otitis media |
| CN107714840A (en) * | 2017-11-27 | 2018-02-23 | 竹溪县明俊意蜂养殖专业合作社 | A kind of Chinese medicine for treating rhinitis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1265909A (en) * | 1999-03-03 | 2000-09-13 | 朱维新 | Capsule for treating rhinitis |
| CN1168456C (en) * | 2000-04-04 | 2004-09-29 | 张忠贵 | Capsule for treating nasosinusitis |
-
2007
- 2007-12-11 CN CN200710009991XA patent/CN101199607B/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815167A (en) * | 2015-05-15 | 2015-08-05 | 王健军 | Traditional Chinese medicine preparation for treating rhinitis |
| CN105168749A (en) * | 2015-09-24 | 2015-12-23 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine composite for treating wind-cold affecting lung syndrome type secretory otitis media |
| CN107714840A (en) * | 2017-11-27 | 2018-02-23 | 竹溪县明俊意蜂养殖专业合作社 | A kind of Chinese medicine for treating rhinitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199607B (en) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488833A (en) | Traditional Chinese medicine preparation possessing efficacy of dispelling wind, ventilating lung, eliminating heat and relieving cough | |
| CN102813839B (en) | Compound medicine for treating cluster headache syndrome | |
| CN102526314A (en) | Medicament for treating inguinal hernia and preparation method for medicament | |
| CN101843694A (en) | Chinese medicament for treating chronic hepatitis | |
| CN101199607B (en) | Bikang tea | |
| CN104353029A (en) | Lung-moistening tangerine peel paste and preparation method thereof | |
| CN104940642A (en) | Dendrobium officinale health care wine having kidney tonifying function and method for preparing the same | |
| CN108671165A (en) | A kind of traditional Chinese herbal decoction for treating female climacteric syndrome | |
| CN107582702A (en) | Medicine Wax composition for traditional Chinese medical science wax therapy and preparation method thereof | |
| CN106138785A (en) | One treats neurasthenic Chinese medicine composition and preparation method thereof | |
| CN104353045A (en) | Walnut cream with asthma preventing effect | |
| CN103599185B (en) | A kind of Chinese medicine composition being used for the treatment of headache | |
| CN101843707B (en) | Chinese medicament for treating chronic hepatitis | |
| CN104367975A (en) | Flos farfarae paste for relieving cough and eliminating phlegm | |
| CN102319348B (en) | Medicament for treating chronic pharyngitis | |
| CN101954030B (en) | Oral medicament for treating diabetes mellitus | |
| CN109157569A (en) | A kind of temperature pain is relaxed plastics and preparation method | |
| CN100348252C (en) | Chinese medicinal product for protecting liver and freezing bowel | |
| CN101112602B (en) | Medicine for treating pharyngitis and method for preparing the same | |
| CN105832885A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN101703590B (en) | Chinese medicament for treating coronary disease | |
| CN103611116A (en) | Traditional Chinese medicinal composition for treating vomiting of pregnancy | |
| CN103816313B (en) | A pharmaceutical composition for treating simple hyperhidrosis in children | |
| CN106075180A (en) | A kind of Chinese medicine treating intravertebral anesthesia postoperative urine retention and preparation method thereof | |
| CN103933476A (en) | Pharmaceutical composition for treating intercostal neuralgia, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20121211 |